NIPH Clinical Trials Search

Basic Information

Recruitment status
Health condition(s) or Problem(s) studied	Prophylaxis of new type of influenza infection
Date of first enrollment	29/05/2014
Target sample size	150
Countries of recruitment
Study type	Interventional
Intervention(s)	investigational material(s) Generic name etc : KIB-PCI (H5N1 influenza vaccin) INN of investigational material : Therapeutic category code : 631 Vaccines Dosage and Administration for Investigational material : Intramuscular

Outcome(s)

Primary Outcome	SRH antibody titer
Secondary Outcome	Neutralizing antibody titer

Key inclusion & exclusion criteria

Age minimum	Not applicable
Age maximum	<= 19age old
Gender	Both
Include criteria	Healthy Japanese children
Exclude criteria	1) Subjects with history of H5N1 influenza 2) Subjects with history of H5N1 influenza vaccination